683 Capital Management »

89bio shares owned by 683 Capital Management

Quarter-by-quarter ownership of 89bio (ETNB) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in 89bio

Tip: Access up to 7 years of quarterly data

All positions including 89bio held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 89bio by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $168k 11k 15.23
2022-12-31 $282k 22k 12.73

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding 89bio

RA Capital Management
Pentwater Capital Management
BlackRock
Deep Track Capital
Adage Capital Partners GP
Suvretta Capital Management
Vanguard Group
venBio Select Advisor
Glazer Capital
Henderson Group
State Street Corporation
Deutsche Bank Aktiengesellschaft
Westfield Capital Management Company
Geode Capital Management
LMR Partners

View all funds holding 89bio